《生存指南》，2017年第2版，美国国立综合癌症网络（NCCN）肿瘤临床实践指南
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
作者信息
Denlinger Crystal S, Sanft Tara, Baker K Scott, Baxi Shrujal, Broderick Gregory, Demark-Wahnefried Wendy, Friedman Debra L, Goldman Mindy, Hudson Melissa, Khakpour Nazanin, King Allison, Koura Divya, Kvale Elizabeth, Lally Robin M, Langbaum Terry S, Melisko Michelle, Montoya Jose G, Mooney Kathi, Moslehi Javid J, O'Connor Tracey, Overholser Linda, Paskett Electra D, Peppercorn Jeffrey, Rodriguez M Alma, Ruddy Kathryn J, Silverman Paula, Smith Sophia, Syrjala Karen L, Tevaarwerk Amye, Urba Susan G, Wakabayashi Mark T, Zee Phyllis, Freedman-Cass Deborah A, McMillian Nicole R
出版信息
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.
Abstract
Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.
摘要
许多癌症幸存者会经历更年期症状，包括服用芳香化酶抑制剂或有卵巢切除术或化疗史的女性幸存者，以及接受或正在接受雄激素剥夺疗法的男性幸存者。性功能障碍在癌症幸存者中也很常见。性功能障碍和更年期相关症状会增加痛苦，并对生活质量产生重大负面影响。《NCCN生存指南》的这一部分提供了关于性功能障碍和更年期症状的筛查、评估和治疗的建议，以帮助在治疗后阶段与成年期癌症幸存者打交道的医疗保健专业人员。
相似文献
1
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.《生存指南》，2017年第2版，美国国立综合癌症网络（NCCN）肿瘤临床实践指南
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.
2
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.生存状况，第 2.2018 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Oct;16(10):1216-1247. doi: 10.6004/jnccn.2018.0078.
3
NCCN Guidelines Insights: Survivorship, Version 1.2016.美国国立综合癌症网络（NCCN）指南解读：癌症生存，2016年第1版
J Natl Compr Canc Netw. 2016 Jun;14(6):715-24. doi: 10.6004/jnccn.2016.0073.
4
NCCN Guidelines® Insights: Survivorship, Version 1.2022.NCCN 指南®洞察：生存版，第 1.2022 版。
J Natl Compr Canc Netw. 2022 Oct;20(10):1080-1090. doi: 10.6004/jnccn.2022.0052.
5
NCCN Guidelines Insights: Survivorship, Version 2.2020.NCCN 指南解读：生存问题，第 2.2020 版。
J Natl Compr Canc Netw. 2020 Aug;18(8):1016-1023. doi: 10.6004/jnccn.2020.0037.
6
NCCN Guidelines® Insights: Survivorship, Version 1.2023.NCCN 指南®洞察：生存问题，第 1.2023 版。
J Natl Compr Canc Netw. 2023 Aug;21(8):792-803. doi: 10.6004/jnccn.2023.0041.
7
Survivorship: introduction and definition. Clinical practice guidelines in oncology.生存：引言和定义。肿瘤临床实践指南。
J Natl Compr Canc Netw. 2014 Jan;12(1):34-45. doi: 10.6004/jnccn.2014.0005.
8
NCCN Guidelines Insights: Survivorship, Version 2.2019.NCCN 指南解读：生存问题，第 2.2019 版。
J Natl Compr Canc Netw. 2019 Jul 1;17(7):784-794. doi: 10.6004/jnccn.2019.0034.
9
Sexual Function in Cancer Survivors: Updates to the NCCN Guidelines for Survivorship.癌症幸存者的性功能：NCCN 生存指南更新。
J Natl Compr Canc Netw. 2016 May;14(5 Suppl):685-9. doi: 10.6004/jnccn.2016.0193.
10
Survivorship, Version 1.2021.生存状况，版本 1.2021.
J Natl Compr Canc Netw. 2021 Jun 30;19(6):676-685. doi: 10.6004/jnccn.2021.0028.
引用本文的文献
1
Molecular characterization and antibiotic susceptibility of methicillin-resistant in immunocompromised cancer patients.免疫功能低下癌症患者中耐甲氧西林菌株的分子特征及抗生素敏感性
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251352258. doi: 10.1177/03946320251352258. Epub 2025 Aug 25.
2
Perceptions about oncological physiotherapy among health and social care professionals and cancer care managers: a co-design approach for implementation strategies.健康与社会护理专业人员及癌症护理管理人员对肿瘤物理治疗的认知：实施策略的协同设计方法
Support Care Cancer. 2025 Aug 18;33(9):793. doi: 10.1007/s00520-025-09785-z.
3
Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study.调查试验撤稿对医疗证据生态系统的影响（活力研究I）：回顾性队列研究
BMJ. 2025 Apr 23;389:e082068. doi: 10.1136/bmj-2024-082068.
4
Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study.化疗治疗的绝经前乳腺癌患者的临床及生化性闭经——一项前瞻性队列研究
BMC Cancer. 2025 Apr 22;25(1):753. doi: 10.1186/s12885-025-14159-z.
5
Breast cancer patients' experience of menopause care in the UK: thematic analysis of free-text comments.英国乳腺癌患者的更年期护理体验：自由文本评论的主题分析
Menopause. 2025 May 1;32(5):409-419. doi: 10.1097/GME.0000000000002505.
6
Patient experience of menopause care after breast cancer in the UK: a cross-sectional study.英国乳腺癌患者绝经后护理的体验：一项横断面研究。
Menopause. 2025 May 1;32(5):396-408. doi: 10.1097/GME.0000000000002504.
7
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.早期三阴性乳腺癌中 Her2 状态的预后影响：土耳其肿瘤学组（TOG）研究。
Sci Rep. 2024 Oct 9;14(1):23556. doi: 10.1038/s41598-024-75293-5.
8
Sleep disturbances based on patient reported outcomes in patients with breast cancer.基于患者报告结局的乳腺癌患者睡眠障碍情况
Sleep Breath. 2024 Dec;28(6):2491-2500. doi: 10.1007/s11325-024-03150-w. Epub 2024 Sep 3.
9
Characterization of cancer survivors clustered by subjective and objective cognitive function scores.基于主观和客观认知功能评分聚类的癌症幸存者特征分析。
Cancer Med. 2024 Jun;13(12):e7255. doi: 10.1002/cam4.7255.
10
Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial.多因素试验优化互联网干预乳腺癌后性健康的研究：WF-2202 性健康和亲密关系增强（SHINE）试验方案。
JMIR Res Protoc. 2024 Aug 19;13:e57781. doi: 10.2196/57781.
本文引用的文献
1
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.阴道内使用6.5毫克（0.50%）普拉睾酮、0.3毫克结合雌激素和10微克雌二醇对外阴阴道萎缩症状的比较。
J Steroid Biochem Mol Biol. 2017 Nov;174:1-8. doi: 10.1016/j.jsbmb.2017.03.014. Epub 2017 Mar 18.
2
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial.基于互联网的认知行为疗法对改善乳腺癌幸存者性功能的疗效：一项随机对照试验的结果。
J Clin Oncol. 2017 Apr 20;35(12):1328-1340. doi: 10.1200/JCO.2016.69.6021. Epub 2017 Feb 27.
3
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.男性儿童、青少年和青年癌症幸存者性腺毒性监测建议：国际儿童癌症后遗症指南协调组与泛癌生存研究合作的报告。
Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8.
4
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
5
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.性欲减退障碍：国际女性性健康研究学会（ISSWSH）专家共识小组综述
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
6
Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.电针与加巴喷丁治疗潮热的乳腺癌幸存者睡眠障碍的比较效果：一项随机试验。
Menopause. 2017 May;24(5):517-523. doi: 10.1097/GME.0000000000000779.
7
Patient-provider communication about sexual concerns in cancer: a systematic review.癌症患者与医护人员就性问题进行的沟通：一项系统综述。
J Cancer Surviv. 2017 Apr;11(2):175-188. doi: 10.1007/s11764-016-0577-9. Epub 2016 Nov 17.
8
Mind-body interventions for vasomotor symptoms in healthy menopausal women and breast cancer survivors. A systematic review.针对健康绝经后女性和乳腺癌幸存者血管舒缩症状的身心干预措施。一项系统评价。
J Psychosom Obstet Gynaecol. 2017 Sep;38(3):210-225. doi: 10.1080/0167482X.2016.1235147. Epub 2016 Nov 11.
9
Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.接受芳香化酶抑制剂治疗早期乳腺癌的女性中，阴道用睾酮乳膏与雌二醇阴道环治疗阴道干燥或性欲降低的随机临床试验。
JAMA Oncol. 2017 Mar 1;3(3):313-319. doi: 10.1001/jamaoncol.2016.3904.
10
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.帕罗西汀在妇科癌症幸存者潮热管理中的作用：首个单中心随机对照试验的结果
Gynecol Oncol. 2016 Dec;143(3):584-588. doi: 10.1016/j.ygyno.2016.10.006. Epub 2016 Oct 15.
Zotero 插件